Understanding Semaglutide Therapy

Semaglutide, a GLP-1 receptor agonist, represents a significant advancement in treating people with type 2 diabetes and obesity. This medication mimics the natural GLP-1 hormone to regulate blood sugar level while promoting weight loss.

Mechanism of Action

Semaglutide works through multiple pathways:

1. Stimulates insulin secretion when high blood sugar is detected
2. Suppresses glucagon production
3. Slows gastric emptying to enhance satiety
4. Acts on brain receptors to reduce appetite

Clinical Benefits

• Significant HbA1c reduction (1.0-1.8%)
• Average body weight loss of 10-15% in clinical trials
• Improved cardiovascular outcomes
• Reduced need for additional diabetes medications

Administration Guidelines

• Inject subcutaneously once weekly (any time of day)
• Rotate between abdomen, thigh, or upper arm
• May take with or without food
• Always check your blood sugar regularly
• Combine with diet and exercise for optimal results

Managing Side Effects

Common gastrointestinal effects (usually temporary):

• Nausea (gradually increases dose to minimize)
• Diarrhea or constipation
• Trouble swallowing (rare)
• Abdominal discomfort

Serious but rare complications requiring immediate attention:

• Severe abdominal pain (possible pancreatitis)
• Kidney failure symptoms (reduced urine output)
• Vision changes (blurred vision)

Patient Monitoring Requirements

• Regular HbA1c testing (every 3-6 months)
• Frequent blood sugar level monitoring
• Annual comprehensive eye exams
• Periodic thyroid exams
• Weight and BMI tracking